Arcturus Therapeutics Holdings (ARCT) EBT (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) reported EBT of -$28.9 million for Q1 2026, down 105.53% on a YoY basis from $522.8 million in Q1 2025, and up 0.52% quarter-over-quarter from -$29.1 million in Q4 2025.
Arcturus Therapeutics Holdings (ARCT) EBT (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings has reported EBT for 9 years, with the latest figure at -$28.9 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 105.53% year-over-year to -$28.9 million; the trailing twelve-month figure through Mar 2026 stood at -$80.6 million (down 17.6% YoY), and the FY2025 full-year result was -$65.8 million, up 18.73% from the prior year.
- EBT for Q1 2026 stood at -$28.9 million, up from -$29.1 million in the prior quarter.
- The five-year high for EBT was $118.6 million in Q4 2022, with the low at -$52.0 million in Q2 2023.
- Historically, EBT has averaged -$11.3 million across 5 years, with a median of -$17.4 million in 2024.
- Annual changes were most pronounced in 2022 — EBT soared 415.16% — and 2024, when it slumped 162.2%.
- Arcturus Therapeutics Holdings' EBT stood at $118.6 million in 2022, then tumbled by 109.65% to -$11.4 million in 2023, then sank by 162.2% to -$30.0 million in 2024, then grew by 3.09% to -$29.1 million in 2025, then grew by 0.52% to -$28.9 million in 2026.
- The last three EBT figures came in at -$28.9 million (Q1 2026), -$29.1 million (Q4 2025), and -$13.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | -28.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.93 Mn |
| Dec 31, 2025 | -29.08 Mn |
| Sep 30, 2025 | -13.45 Mn |
| Jun 30, 2025 | -9.18 Mn |
| Mar 31, 2025 | -14.08 Mn |
| Dec 31, 2024 | -30.01 Mn |
| Sep 30, 2024 | -7.12 Mn |
| Jun 30, 2024 | -17.37 Mn |
| Mar 31, 2024 | -26.45 Mn |
| Dec 31, 2023 | -11.45 Mn |
| Sep 30, 2023 | -15.33 Mn |
| Jun 30, 2023 | -51.97 Mn |
| Mar 31, 2023 | 50.86 Mn |
| Dec 31, 2022 | 118.64 Mn |
| Sep 30, 2022 | -35.27 Mn |
| Jun 30, 2022 | -21.56 Mn |
| Mar 31, 2022 | -51.17 Mn |
| Dec 31, 2021 | -37.65 Mn |
| Sep 30, 2021 | -53.82 Mn |
| Jun 30, 2021 | -53.72 Mn |